Asterand, Laureate Pharma, PPD and Kendle - People on the move

By Emilie Reymond

- Last updated on GMT

Related tags Vice president Management occupations

Asterand, Laureate Pharma, PPD and Kendle have all had people on
the move in the world of pharmaceutical outsourcing this past week.

Preclinical services firm Asterand​ has announced the departure of Ronald Openshaw, the company's CFO. Openshaw will step down after the firm publishes its annual results later this month. Openshaw acted as CEO to Pharmagene prior to the merger between the two firms. He has decided not to pursue an application to succeed the current CEO. Biopharmaceutical services company Laureate Pharma​ has also announced some shake up among its Board. The firm has elected Tracy Ken Tsuetaki as non-executive chairman of its Board of Directors. Tsuetaki is currently president of medical communications and consulting at Quintiles where he is responsible for their global consulting and medical education groups. Previously, he was senior vice president of Global Business Development for the company. Meanwhile, PPD​ has promoted Andy Strayer, Sue Stansfield, Mark Roseman and Randy Marchbanks last week. Strayer becomes vice president of clinical operations for the Americas and Asia, while Stansfield will serve the same role for the Europe region. Roseman was promoted to vice president of clinical operations and will be based in the firm's North Carolina office, and Marchbanks will assume the role of vice president of business for the Americas, being responsible for Phase II-IV business. PPD also announced the departure of Colin Shannon from its position as executive vice president of global clinical operations. Other exits were announced last week. David Jones, chairman of the board of Hospira​ announced he will retire from the board at the end of his term next May. He will be replaced by the company CEO Christopher Begley. In other news, contract research organisation (CRO) Kendle​ has decided to further strengthen its global clinical development operations with a number of appointments. The firm has promoted Martha Feller to senior vice president of global clinical development, while Ubavka Denoble and Judith Swilley are appointed vice president and senior director respectively. Kendle said it expects these recently announced appointments to drive continued growth in its Phase II-III business.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars